Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus

doi:10.5662/wjm.v12.i4.246

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6397)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

320

WORD

HTML

4338

Figures (1-2)

269

Tables (1-1)

323

Sum=5337

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

379

Download

681

Sum=1060

Jul 20, 2022 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Methodol. Jul 20, 2022; 12(4): 246-257
Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.246

Full Size Figure Download Figure

Figure 1 Gut dysbiosis and its role in pathophysiology of type 2 diabetes mellitus and cardio-metabolic diseases.

Citation: Kant R, Chandra L, Verma V, Nain P, Bello D, Patel S, Ala S, Chandra R, Antony MA. Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus. World J Methodol 2022; 12(4): 246-257
URL: https://www.wjgnet.com/2222-0682/full/v12/i4/246.htm
DOI: https://dx.doi.org/10.5662/wjm.v12.i4.246